XenMatrix AB Surgical Graft
FDA 510(k) K151177 · C. R. Bard
510(k) numberK151177
Submission
- Device name
- XenMatrix AB Surgical Graft
- Applicant
- C. R. Bard
Warwick, RI, US - Received
- May 1, 2015
- Decision date
- July 30, 2015
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- PIJ – Collagen Surgical Mesh Containing Drugs
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 878.3300
- Specialty
- General, Plastic Surgery
- Implant
- Yes
Reinforcement of soft tissue where weakness exists.
Other 510(k)s with product code PIJ
More from C.R. Bard, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K253514 | Minnesota Four-Lumen Esophagogastric Tamponade Tube - 18 French (0092220); Blakemore…KNT · Traditional | 07/10/2026SE |
| K254076 | BD Touchless Plus Unisex Pre-Lubricated Urethral Catheter KitFCM · Traditional | 05/29/2026SESK |
| K252971 | Elyra Thulium Fiber Laser System and Elyra Plus Thulium Fiber Laser System (Laser…GEX · Traditional | 03/17/2026SE |
| K251864 | Rubber Utility CatheterKOD · Traditional | 02/23/2026SE |
| K251186 | Bard® Temporary Pacing Electrode Catheter Needle / Cannula (Introducer)LDF · Special | 05/15/2025SE |
| K241334 | Semi-Floating Temporary Pacing Electrode Catheter, Bipolar, Stainless Steel Electrodes…LDF · Traditional | 01/31/2025SE |
| K230356 | Aspirex Thrombectomy SystemQEW · Traditional | 03/31/2023SE |
| K223177 | Highlander 014 PTA Balloon Dilatation CatheterLIT · Traditional | 01/20/2023SE |
| K222793 | WavelinQ GeneratorGEI · Special | 10/17/2022SE |
| K220270 | Aspirex Thrombectomy SystemQEW · Traditional | 06/21/2022SE |
Questions and answers
When was XenMatrix AB Surgical Graft cleared by the FDA?
XenMatrix AB Surgical Graft (K151177) received a 510(k) decision of Substantially Equivalent on July 30, 2015, 90 days after the submission was received.
What is the product code of K151177?
The FDA product code is PIJ – Collagen Surgical Mesh Containing Drugs, a Class II (moderate risk) device regulated under 21 CFR 878.3300.